Clinical Usefulness and Quality of Life of OROS Hydromorphone in Strong Opioid-Naive Cancer Pain Patients; Multicenter, Prospective, Open-Label and Observational Study.

Trial Profile

Clinical Usefulness and Quality of Life of OROS Hydromorphone in Strong Opioid-Naive Cancer Pain Patients; Multicenter, Prospective, Open-Label and Observational Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2014

At a glance

  • Drugs Hydromorphone (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen
  • Most Recent Events

    • 31 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Oct 2012 Planned End Date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top